Inactive Instrument

Hercules Technology Growth Capital Inc Share Price Nasdaq

Equities

US4270965084

Investment Management & Fund Operators

Sales 2024 * 509M 42.51B Sales 2025 * 553M 46.12B Capitalization 3.22B 269B
Net income 2024 * 341M 28.45B Net income 2025 * 345M 28.79B EV / Sales 2024 * 6.33 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 5.83 x
P/E ratio 2024 *
9.55 x
P/E ratio 2025 *
9.9 x
Employees -
Yield 2024 *
7.94%
Yield 2025 *
8.21%
Free-Float 98.08%
More Fundamentals * Assessed data
Dynamic Chart
NeueHealth, Inc Secures Up to $150 Million in New Term Loan Facility with Hercules Capital CI
Cybersecurity firm Semperis raises $125 mln from JP Morgan, Hercules Capital RE
Semperis Inc. announced that it has received $125 million in funding from Hercules Capital, Inc., JP Morgan Asset Management CI
UBS Adjusts Price Target on Hercules Capital to $18.50 From $18, Maintains Neutral Rating MT
Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital MT
Haveli Investments Software Fund I, L.P., a fund managed by Haveli Investment Management LLC completed the acquisition of ZeroFox Holdings, Inc. (NasdaqGM : ZFOX) from Monarch Alternative Capital LP and Others. CI
X4 Pharmaceuticals Receives $125 Million Additional Capital; Shares Rise MT
Verona Pharma Signs Financing Agreements for Up to $650 Million MT
Transcript : Hercules Capital, Inc., Q1 2024 Earnings Call, May 02, 2024
Hercules Capital, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Hercules Capital, Inc. Declares First Quarter Cash Dividend, Payable on May 14, 2024 CI
Hercules Capital Signs $35 Million Loan Facility to Fund Development of Tenosynovial Giant Cell Tumour Treatment MT
KARL STORZ SE & Co. KG entered into an agreement to acquire Asensus Surgical, Inc. for $100 million. CI
Bluebird bio to Restate Financial Statements; Shares Fall MT
JMP Securities Adjusts Hercules Capital Price Target to $19 From $18, Maintains Market Outperform Rating MT
More news

Latest transcript on Hercules Technology Growth Capital Inc

Managers TitleAgeSince
Chief Executive Officer 45 17/10/17
Director of Finance/CFO 55 04/19/04
Compliance Officer - -
Members of the board TitleAgeSince
Director/Board Member 73 04/19/04
Chairman 71 01/06/01
Director/Board Member 61 26/23/26
More insiders
Hercules Capital, Inc. is a specialty finance company. The Company is focused on providing financing solutions to venture capital-backed and institutional-backed companies in a variety of technology, life sciences and sustainable and renewable technology industries. It is structured as an internally managed, non-diversified, closed-end investment company. Its business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments in primarily Structured Debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology related industries at attractive yields. It invests in a range of companies active in the technology industry sub-sectors characterized by products or services that require advanced technologies, including, computer software and hardware, networking systems, semiconductors, semiconductor capital equipment, information technology infrastructure and others.
More about the company